XML 72 R28.htm IDEA: XBRL DOCUMENT v3.23.3
Organization and Business - Narrative (Details)
1 Months Ended 3 Months Ended 9 Months Ended 12 Months Ended
May 30, 2023
USD ($)
shares
Mar. 31, 2021
USD ($)
Sep. 30, 2023
USD ($)
Jun. 30, 2023
USD ($)
shares
Sep. 30, 2023
USD ($)
patent
Sep. 30, 2022
USD ($)
Dec. 31, 2022
USD ($)
May 28, 2021
USD ($)
Debt Instrument [Line Items]                
Number of patents issued | patent         19      
Number of pending patents | patent         8      
Cash and cash equivalents     $ 7,000,000.0   $ 7,000,000.0      
Net working capital     1,700,000   1,700,000      
Accumulated deficit     (165,045,881)   (165,045,881)   $ (157,057,558)  
Payments to acquire investments   $ 2,000,000            
Cash deposited, interest-bearing   $ 10,000,000            
Capital raise, net of issuance costs         3,665,000 $ 0    
Common Share Or Stock Member                
Debt Instrument [Line Items]                
Shares issued in registered direct offering (in shares) | shares       173,558        
Capital raise, net of issuance costs       $ 63,136        
Commissions       $ 1,902        
Money Market Funds and Marketable Debt and Equity Securities                
Debt Instrument [Line Items]                
Investment in cash equivalents and marketable debt and equity securities     $ 68,000   $ 68,000      
Registered Direct Offering                
Debt Instrument [Line Items]                
Sale of stock, consideration received on transaction $ 4,000,000              
Shares issued in registered direct offering (in shares) | shares 16,000,000              
Sales Agreement                
Debt Instrument [Line Items]                
Sale of stock, consideration received on transaction, authorized amount               $ 14,611,900
Period for which advance notice is due to terminate agreement               10 days
Commission fee, percent               3.00%
Net Revenue | Customer Concentration Risk | Customer One, Two, and Three                
Debt Instrument [Line Items]                
Percentage of concentration risk     87.20%   79.80%      
Net Revenue | Customer Concentration Risk | Customer One                
Debt Instrument [Line Items]                
Percentage of concentration risk     75.00%   57.60%      
Net Revenue | Customer Concentration Risk | Customer Two                
Debt Instrument [Line Items]                
Percentage of concentration risk     10.00%   15.60%      
Net Revenue | Customer Concentration Risk | Customer Three                
Debt Instrument [Line Items]                
Percentage of concentration risk     2.20%   6.70%      
Accounts Receivable | Customer Concentration Risk | Customer One, Two, and Three                
Debt Instrument [Line Items]                
Percentage of concentration risk         55.20%      
Accounts Receivable | Customer Concentration Risk | Two Largest Customers                
Debt Instrument [Line Items]                
Percentage of concentration risk             23.90%